Literature DB >> 4586631

Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy.

P J Hubner, G M Ziady, G K Lane, T Hardarson, B Scales, C M Oakley, J F Goodwin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4586631      PMCID： PMC458765          DOI： 10.1136/hrt.35.11.1116

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  19 in total

Review 1.  Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs.

Authors:  C T Dollery; J W Paterson; M E Conolly
Journal:  Clin Pharmacol Ther       Date:  1969 Nov-Dec       Impact factor: 6.875

2.  Muscular subaortic stenosis. Prevention of outflow obstruction with propranolol.

Authors:  M D Flamm; D C Harrison; E W Hancock
Journal:  Circulation       Date:  1968-11       Impact factor: 29.690

3.  Assessing reports of therapeutic trials.

Authors:  N D Lionel; A Herxheimer
Journal:  Br Med J       Date:  1970-09-12

4.  Multicenter trial of propranolol in angina pectoris.

Authors:  R H Grant; P Keelan; R J Kernohan; J C Leonard; L Nancekievill; K Sinclair
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

5.  Bedside technics for the evaluation of ventricular function in man.

Authors:  A M Weissler; W S Harris; C D Schoenfeld
Journal:  Am J Cardiol       Date:  1969-04       Impact factor: 2.778

6.  Effect of propranolol on left ventricular work in aortic stenosis.

Authors:  J Hamer; J Fleming
Journal:  Br Heart J       Date:  1967-11

7.  Amelioration of angina pectoris in idiopathic hypertrophic subaortic stenosis with beta-adrenergic blockade.

Authors:  L S Cohen; E Braunwald
Journal:  Circulation       Date:  1967-05       Impact factor: 29.690

8.  Propranolol in management of muscular subaortic stenosis.

Authors:  G Sloman
Journal:  Br Heart J       Date:  1967-09

9.  Practolol in treatment of angina pectoris. A double-blind trial.

Authors:  C F George; R E Nagle; B L Pentecost
Journal:  Br Med J       Date:  1970-05-16

10.  Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris.

Authors:  G Sandler; G A Clayton
Journal:  Br Med J       Date:  1970-05-16
View more
  11 in total

1.  Left ventricular filling in hypertrophic cardiomyopathy. An angiographic study.

Authors:  J E Sanderson; D G Gibson; D J Brown; J F Goodwin
Journal:  Br Heart J       Date:  1977-06

2.  Effect of propranolol upon protein and proteolytic synthesis activity in hypertrophic myocardium.

Authors:  B Kwiatkowska-Patzer; T Zalewska
Journal:  Basic Res Cardiol       Date:  1988 Jan-Feb       Impact factor: 17.165

3.  Editorial: Hypertrophic cardiomyopathy.

Authors: 
Journal:  Br Med J       Date:  1974-05-11

4.  Treatment of hypertrophic obstructive cardiomyopathy with verapamil.

Authors:  M Kaltenbach; R Hopf; G Kober; W D Bussmann; M Keller; Y Petersen
Journal:  Br Heart J       Date:  1979-07

5.  Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy.

Authors:  K Landmark; S Sire; E Thaulow; J P Amlie; S Nitter-Hauge
Journal:  Br Heart J       Date:  1982-07

6.  Reversible ischaemia in hypertrophic cardiomyopathy.

Authors:  H Thomson; W Fong; W Stafford; M Frenneaux
Journal:  Br Heart J       Date:  1995-09

7.  Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs.

Authors:  R F Alvares; J F Goodwin
Journal:  Br Heart J       Date:  1982-09

8.  Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function.

Authors:  D M Anderson; G L Raff; T A Ports; B H Brundage; W W Parmley; K Chatterjee
Journal:  Br Heart J       Date:  1984-05

9.  Effect of propranolol on the activity of neutral, alkaline and acidic proteases in rat myocardium after aortic stenosis.

Authors:  B Kwiatkowska-Patzer; T Zalewska
Journal:  Basic Res Cardiol       Date:  1987 Jan-Feb       Impact factor: 17.165

10.  Current management of hypertrophic cardiomyopathy.

Authors:  Caroline J Coats; Perry M Elliott
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.